EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (Under Process) , 

 ISSN 2394-3211

Impact Factor: 4.897

 ICV - 79.57

Abstract

THE OVERVIEW OF BREAST CANCER STATISTICS AT CATANDUVA-SP IN BRAZIL: INCIDENCE, MORTALITY, SURVIVAL AND SCREENING

Michelle Rabello Tacconi*, Marília de Jesus Nogueira, Letícia Menegossi, Gabriela Salles Figueiredo, Fabiola Silva Garcia Praça and Wanessa Silva Garcia Medina

ABSTRACT

According to data in the statistics of the National Cancer Institute José Alencar Gomes da Silva (INCA) and the Ministry of Health (MS) estimates the occurrence of about 600 thousand new cases of cancer in Brazil in 2018. The precise number of the estimate is of 582.590 new cases of cancer being 282.450 in women and 300.140 in men of which female breast cancer reaches the number 59.700 new cases for biennium 2018-2019. In this article, we provide an overview of breast cancer statistics at Catanduva-SP in Brazil, including data on incidence, mortality, survival, and screening. Data from the years 2010 to 2015 of patients undergoing clinical therapy at Hospitals Padre Albino and Emilio Carlos, in Catanduva-SP, Brazil were analysed based on breast cancer incidence, demographic data, administered drug agents, medical history, clinical history, mortality and survival rates. The results were compared with those described by the INCA and data obtained in the scientific literature. In our studies, we showed that 25% of the cancer case treated during 2010-2015 at Catanduva-SP, were diagnosed as breast cancer and almost 99% were female, racially identified as caucasian and African (85 and 15%, respectively). The average age was 55 years old and 33.6% of these women had received mastectomy while 03 patients did not have a surgical intervention as part of breast cancer treatment. In addition, chemotherapy was used after surgery only in 6% of the patients. Finally, death number observed for breast cancer was 4.5%. Since 1990, breast cancer death rates have dropped by 34% and this decrease was evident in all racial/ethnic groups. Nevertheless, survival disparities persist by race/ethnicity, with which African American women having the poorest breast cancer survival when compared to any racial/ethnic group. Sustained and increased efforts to provide high-quality screening, diagnosis, and treatment to all segments of the population are needed to achieve continued progress in the breast cancer control.

Keywords: breast cancer, race/ethnicity, chemotherapy.


[Full Text Article]

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 March 2019 Issue has been Published, Kindly check it on http://www.ejpmr.com/home/current_issues

  • EJPMR MARCH ISSUE PUBLISHED

    MARCH 2019 Issue has been successfully launched on 1 March 2019

  • EJPMR New Impact Factor

    Its our Pleasure to Inform you that EJPMR Impact Factor has been increased from 4.161 to 4.897 due to high quality Publication at International Level

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (Under Process)